Health Canada suspended Grifols’ license to collect plasma at its Taylor Avenue centre in Winnipeg over quality-management concerns. Grifols says operations are unaffected because it had already voluntarily stopped collection there.
The Globe and Mail reported that Health Canada’s concerns followed a donor’s death last year. CBC News reported that two people died in October 2025 and January 2026 after donating plasma at Grifols clinics in Winnipeg, including Taylor Avenue. Grifols said donor and patient safety, and the quality and safety of plasma collected at Taylor Avenue and its other Canadian centres, had not been compromised.
Grifols said it is working with Health Canada on a reopening plan and has reviewed operations across its centres, retrained staff, and enhanced procedures and quality systems. After deficiencies were identified at several centres, the company said it accelerated its acquisition of Canada Plasma Inc.’s remaining stake to take full management control; governance arrangements had previously limited its ability to direct the business.
